Alteration of lncRNA RHPN1-AS1 predicts clinical prognosis and regulates the progression of bladder cancer via modulating miR-485-5p
RHPN1-AS1 serves as a prognostic biomarker and tumor promoter in bladder cancer via modulating miR-485-5p, which might be a reliable target of bladder cancer therapy.
Authors
- Jianchao Zhang (ORCID: https://orcid.org/0009-0003-4626-8563)
- Jingmin Zhou
- Yulong Sheng
- De-Qi Jiang (ORCID: https://orcid.org/0000-0001-6684-3789)
- Shuhui Li (ORCID: https://orcid.org/0009-0001-1997-4097)
- Lin Cheng
- Jinshan Xu
Institutions
- Qingdao University (CN)
- Second Military Medical University (CN)
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Peking Union Medical College Hospital (CN)
- Changhai Hospital (CN)
- Shandong Provincial Hospital (CN)
- Affiliated Hospital of Qingdao University (CN)
Publication Details
- Journal
- The International Journal of Biological Markers
- Published
- 2024-09-05
- DOI
- https://doi.org/10.1177/03936155241281076
- Citations
- 1
- Primary Topic
- Cancer-related molecular mechanisms research
- Type
- article
- Field-Weighted Citation Impact
- 0.29